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LETTERS TO THE EDITOR
Novel Transglutaminase 1 Gene Mutations (R348X/Y365D)
in a Japanese Family with Lamellar Ichthyosis
To the Editor:
Autosomal recessive ichthyoses are inherited skin disorders char-
acterized by generalized scaling, hyperkeratosis, and variable
erythema. Newborns often present with a shiny, thick, and taut
encasement called a collodion membrane. After releasing from
this encasement, those patients who develop large thick brown
scales on the entire body with ectropion, scarring alopecia, and
palmoplantar keratoderma, with limited or no erythema, are
now classi¢ed as having lamellar ichthyosis (LI) (OMIM number
242100) (Williams and Elias, 1985).
Figure1. Identi¢cation and veri¢cation ofTGM1mutations in the family with LI. (A) The following primers were used to amplify 378 bp segment
of exon 7 sequences: sense primer, 50 -GCTCAGGCGGGTGTCTGGAT-30; anti-sense primer, 50 -CTGGCTTTCCTCCCTTCTCC-30. Heteroduplex ana-
lysis of DNA corresponding to exon 7 from proband (II-1) revealed two heteroduplex bands (upper and lower arrows), as compared with the DNA of the
unrelated healthy control (c). (B) Sequencing of PCR products of II-1 and I-1 revealed a heterozygous C-to-T transition at nucleotide position 1159 (arrows),
resulting in a substitution of arginine 348 by stop codon. (C) The R348X mutation created a new restriction enzyme site for DdeI. (D) Sequencing of PCR
products of II-1 and I-2 revealed a heterozygous T-to-G transversion at nucleotide position 1209 (arrow), resulting in a substitution of tyrosine 365 by
aspartic acid. (E) The maternal mutationY365D abolished a restriction enzyme site forAluI.
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A large body of immunohistochemical (Hohl et al, 1993), ge-
netic linkage (Russell et al, 1994), and DNA sequencing (Huber
et al, 1995a; Russell et al, 1995; Laiho et al, 1997; Hennies et al,
1998) data have shown that many cases of LI are caused by muta-
tions in theTGM1 gene encoding the transglutaminase 1 (TGase
1) enzyme. TGase 1 catalyzes the formation of e-(g-glutamyl)-ly-
sine cross-links between such proteins as involucrin and loricrin
used to form the corni¢ed cell envelop of terminally di¡erentiat-
ing keratinocytes (Thacher and Rice, 1985; Steinert and Marekov,
1997). Furthermore, a phenotype reminiscent of patients with LI
has been replicated inTGM1 knockout mice (Matsuki et al, 1998).
It should be pointed out, however, that a number of patients with
an LI-like phenotype have normal TGase 1 expression, absence of
linkage to theTGM1 locus, and no detectableTGM1 mutation
(Huber et al, 1995b; Parmentier et al, 1995; Bale et al, 1996). LI has
been linked in other families to loci on chromosomes 2q33^35
(Parmentier et al, 1996).
In this study, we have examined the molecular basis of LI in a
Japanese family and we now report two novelTGM1mutations.
The proband (II-1 in Fig 1) is a 20 y old male who was born as a
‘‘collodion baby’’ at birth and later developed large thick brown
hyperkeratotic scales on the entire body with marked ectropion,
mild palmoplantar keratoderma, and mild erythema, typical of
the LI phenotype. Scarring alopecia was not seen. Skin biopsy of
the patient revealed a thickened stratum corneum without para-
keratosis. There was no granular degeneration in the epidermis.
The parents (I-1 and I-2 in Fig 1) were clinically normal and are
unrelated and have no history of ichythotic disorders. Genomic
DNAwas subjected to polymerase chain reaction (PCR) ampli¢-
cation of all 15 TGM1 exons and £anking intronic sequences
(Russell et al, 1995), followed by heteroduplex analysis by confor-
mation-sensitive gel electrophoresis (Ganguly et al, 1993), auto-
mated direct sequencing, and veri¢cation of the mutations by
restriction enzyme digestions. Heteroduplex analysis by confor-
mation-sensitive gel electrophoresis of PCR products spanning
exon 7 ofTGM1 revealed two heteroduplex bands with the pro-
band’s DNA (upper and lower arrows in Fig 1A), which corre-
sponded to those noted in his father and mother, respectively
(Fig 1A). By sequencing, the paternal mutation was a C-to-T
transition at nucleotide position 1159, as compared with the nor-
mal sequence (Yamanishi et al, 1991) (Fig 1B). This nucleotide sub-
stitution changed arginine (CGA) to a stop codon (TGA)
(designated R348X) (Fig 1B). This mutation creates a new re-
striction enzyme site for DdeI (Fig 1C). The normal 378 bp PCR
product was digested to 149 bp, 134 bp, 73 bp, 20 bp, and 2 bp frag-
ments, but in the mutated allele, the 149 bp fragment appeared as
103 bp and 46 bp fragments instead (Fig 1C).We con¢rmed that
the proband and his father were heterozygotes for the mutation,
whereas his mother carried the normal allele only. The R348X
mutation results in the loss of the terminal 343 amino acids, in-
cluding the essential active site triad residues of the catalytic core
domain, and the b-barrel 1 and 2 domains. As the entirety and
integrity of the core domain is essential for enzyme activity (Yee
et al, 1994; Noguchi et al, 2001), it is clear that this truncated mu-
tant form of TGase 1will have no activity.The maternal mutation
was a T-to-G substitution at nucleotide position 1209, as com-
pared with the normal sequence (Fig 1D), which changed tyro-
sine (TAC) to aspartic acid (GAC) (designated Y365D). This
mutation resulted in the loss of a restriction enzyme site forAluI
(Fig 1E). The normal 378 bp PCR product resulted in 248 bp and
130 bp fragments, but the PCR product containing the mutation
resisted digestion (Fig 1E).The proband and his mother were het-
erozygotes for this mutation, whereas his father carried the nor-
mal allele only (Fig 1E). Neither mutation was a common
polymorphism because examination of 110 alleles in normal con-
trol individuals failed to reveal the substitutions. In order to ana-
lyze the structural e¡ect of Y365D mutation, a three-dimensional
model of the structure of human TGase 1 was generated on the
basis of the known atomic structure of human factor XIIIa as de-
scribed (Candi et al, 1998). TheY365 residue has been conserved in
relative position in all TGases, and its side chain is buried in a hy-
drophobic pocket formed by residuesY302, I360,V371, I337,V336,
M327, and is capped by R306 (Fig 2). This region is located im-
mediately above the active site catalytic triad of cysteine, histidine,
and aspartic acid residues, and its integrity is essential for enzyme
activity. Substitution of Y365 with the smaller aspartic acid resi-
due will destabilize the organization of this hydrophobic pocket
in two ways: by allowing the entrance of water molecules to ¢ll
the gap; and by formation of aberrant H-bonds between the oxy-
gens of the carboxylic acid group and the backbone oxygen of
V336. Examination of electron density maps reveals that these
changes will distort the active site region by changing the orien-
tation of the a-helical segment bearing the cysteine residue and
the b-sheet strand bearing the histidine residue. Thus the muta-
tion will likely result in loss of enzyme activity. Analyses of this
mutation thus o¡er new insights on the importance of residues
surrounding the active site of the TGase 1 enzyme.
In summary, LI phenotype of this proband can be explained by
the prediction that each of the maternally and paternally derived
mutations will likely result in loss of enzyme activity.
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Figure 2. Modeling of the Y365D mutation. The Y365 residue is lo-
cated in the catalytic core domain just above the active site and is buried
in a hydrophobic pocket that has been conserved in the family of TGase
enzymes. Mutation to a smaller aspartic acid residue will likely allow water
molecules to enter the resultant cavity, and favor the formation of an aber-
rant H-bond with the backbone oxygen of V336. The net result of these
two changes would be to distort the orientation of the active site, resulting
in loss of enzyme activity.
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